Back to Journals » Journal of Experimental Pharmacology » Volume 17
Efficacy of Probiotic Supplements and Topical Applications in the Treatment of Acne: A Scoping Review of Current Results
Authors Sutema IAMP , Latarissa IR , Widowati IGAR, Sartika CR, Ciptasari NWE, Lestari K
Received 30 September 2024
Accepted for publication 18 December 2024
Published 9 January 2025 Volume 2025:17 Pages 1—14
DOI https://doi.org/10.2147/JEP.S498769
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Abdelwahab Omri
Ida Ayu Manik Partha Sutema,1,2 Irma Rahayu Latarissa,1,3 I Gusti Ayu Rai Widowati,2 Cynthia Retna Sartika,1,4 Ni Wayan Eka Ciptasari,5 Keri Lestari1,3,6
1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 2Clinical Pharmacy Study Program, Faculty of Health Sciences, Bali International University, Denpasar, Indonesia; 3Medication Therapy Adherence Clinic (MTAC), Universitas Padjadjaran, Sumedang, Indonesia; 4PT Prodia StemCell Indonesia, Central Jakarta, Jakarta, Indonesia; 5Ngoerah Sun Wellness and Aesthetic Center, Prof. Dr. I.G.N.G. Ngoerah Central General Hospital, Denpasar, Indonesia; 6Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Sumedang, Indonesia
Correspondence: Keri Lestari, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia, Email [email protected]
Abstract: Acne vulgaris is a prevalent dermatological condition characterized by comedones, papules, and pustules, with significant physical and psychological implications. Conventional treatments for this condition, including antibiotics and retinoids, face challenges, such as side effects and antibiotic resistance, necessitating alternative treatments. Recent studies show the potential of probiotics to modulate skin microbiome and alleviate acne symptoms. Therefore, this study aimed to consolidate evidence from randomized controlled trials (RCTs) and clinical investigations, evaluating the efficacy of probiotics in acne management. A comprehensive literature search was conducted across PubMed, Scopus, and Cochrane databases using several keywords, such as “probiotic”, “microbiome”, and “acne vulgaris”. Inclusion criteria are RCTs and clinical studies from 2009 to 2024 examining probiotics for acne treatment. Studies were selected, screened, and analyzed based on population, intervention, design, and results. Descriptive statistics were used to summarize study characteristics. Fifteen studies including 811 participants met the inclusion criteria. The studies tested various oral and topical probiotics, including Lactobacillus, Bifidobacterium, Bacillus, and Enterococcus strains, over treatment periods ranging from 4 to 12 weeks. The results showed that probiotics, reduced acne lesions, improved skin barrier function, and decreased inflammatory markers. Both oral and topical probiotics showed potential in balancing skin microbiome and reducing acne severity. Some studies reported outcomes comparable to conventional acne treatments, such as antibiotics and benzoyl peroxide. However, there is variability in individual responses to different probiotic strains, and potential side effects, though rare, have been reported in some cases. Probiotics presented a natural, effective alternative to conventional acne treatment. However, future studies are needed to determine optimal treatment protocols.
Keywords: probiotics, skin microbiome, acne vulgaris, bacterial imbalance, inflammatory skin conditions
Introduction
Acne vulgaris is one of the most prevalent dermatological conditions globally, affecting individuals across diverse age groups and socioeconomic backgrounds.1 This multifactorial disorder is characterized by the formation of comedones, papules, pustules, and, in severe cases, nodules and cysts. Furthermore, acne vulgaris significantly impacts both physical appearance and psychological well-being.2 Despite the contribution of various factors to its pathogenesis, recent studies show the relationship between skin microbiome and acne development.3,4
Skin, a complex ecosystem hosting a myriad of microbial communities, plays an important role in maintaining cutaneous homeostasis.5 However, perturbations in this delicate balance, termed dysbiosis, have been implicated in acne pathophysiology.3 Propionibacterium acne, now recognized as Cutibacterium acne (C. acne), has been a subject of particular interest due to the association with inflammatory acne lesions.6 A previous study observed alterations in the relative abundance of other commensal and pathogenic bacteria in acne-affected skin, suggesting a broader dysregulation of skin microbiota.7
According to previous studies, the efficacy of current antibiotic treatments for acne has diminished due to increased resistance and reduced effectiveness,8,9 leading to a shift toward novel treatment methods. Probiotics, live microorganisms known for conferring health benefits when administered in sufficient quantities, have surfaced as promising agents in rebalancing the microbiome and alleviating symptoms.3,4 These probiotics have garnered increasing attention for the potential to modulate skin microbiota and mitigate inflammatory skin conditions, including acne vulgaris.10
While the benefits of probiotics have been extensively studied, concerns about potential side effects remain. Some studies have reported mild gastrointestinal discomfort, such as bloating or diarrhea, in individuals consuming certain probiotic strains.11 However, the systemic absorption of probiotics applied topically is minimal, suggesting a lower risk of adverse effects.12 Additionally, clinical trials examining the use of probiotics for acne management have shown minimal safety concerns, further supporting their potential as adjunctive therapies.13
Despite the evidence supporting the plausibility of probiotics as adjunctive therapeutic agents in acne management, a comprehensive evaluation of the efficacy, optimal strains, dosages, and mechanisms of action remains essential. This evaluation consolidates existing evidence from randomized controlled trials (RCT) or clinical studies to assess the potency of probiotics in enhancing microbiome balance and ameliorating acne vulgaris. Therefore, this study aimed to elucidate the potential of probiotics as a promising avenue for future treatment in modulating skin microbiome to alleviate acne-related manifestations.
Methods
A comprehensive search was conducted across PubMed, Scopus, and Cochrane, using keywords, such as “probiotic”, “microbiome”, “acne vulgaris”, “clinical trial”, and “randomized controlled trial” to identify relevant studies. The Boolean operators were adopted, using “OR” to expand the scope within each concept and “AND” to refine the search for pertinent results, aiming to capture a broad and focused selection of relevant studies. All original studies and clinical reports published from 2009 to 2024 regarding the use of probiotics in acne management were included. The inclusion criteria were original studies with RCT designs, as well as interventional and clinical studies investigating the efficacy of probiotics for acne treatment. Exclusion criteria were abstracts from conference proceedings, case reports, commentaries, editorials, and study protocols. Figure 1 shows a detailed selection process of studies.
![]() |
Figure 1 The flowchart of the study selection process. |
The collected information included authorship, methods, country, population/sample size, intervention, study design, duration, and results regarding the role of probiotics in acne vulgaris. The results were analyzed, using a structured method to derive meaningful conclusions. Descriptive statistics were used to delineate the prevalence of specific study characteristics. The results were presented narratively, with extensive discussions to ensure the precision and reliability of the conclusions.
Results
The searches conducted on MEDLINE, Scopus, and Cochrane found 461, 164, and 97 records, respectively, and 722 registers. After eliminating 651 duplicates, 71 records were screened and 40 were identified for full-text assessment. In the final review, 15 studies were included. The selection process is shown in Figure 1 of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart.
Clinical studies collectively enrolled 811 subjects, with each sample size ranging from 20 to 112 per study. Most studies focused on subjects with mild to moderate acne. However, a few trials included more severe forms, such as inflammatory acne or papular pustular rosacea. The age of the subject varied widely, ranging from 12 to 62 years old.
The types of probiotics used in these studies were diverse, covering both oral and topical formulations. Oral probiotics included strains, such as Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus salivarius, Lactobacillus acidophilus, Lactobacillus delbrueckii subspecies bulgaricus, Bacillus indicus, Bacillus subtilis, Bacillus coagulans, Bacillus licheniformis, Bacillus clausii, Escherichia coli Nissle, the cyanobacterium Arthrospira platensis, Bifidobacterium bifidum, Bifidobacterium breve. Meanwhile, topical probiotics included strains, such as Lactobacillus paracasei, Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus pentosus, Enterococcus faecalis, Enterococcus faecalis and Bifidobacterium animalis. Some trials combined probiotics with conventional treatments, such as benzoyl peroxide, isotretinoin, or minocycline.
The experimental periods varied, typically ranging from 4 to 12 weeks, with most studies measuring outcomes at intervals, namely 4, 8, or 12 weeks. Some studies also included shorter treatment periods, such as the 30-day intervention in Ukraine or the 4-week study conducted in Korea. The summaries of the studies on probiotics for acne vulgaris were presented in Tables 1 and 2 for oral and topical probiotics, respectively.
![]() |
Table 1 Efficacy of Oral Probiotic Use in Acne Vulgaris Patients |
![]() |
Table 2 Efficacy of Topical Probiotic Use in Acne Vulgaris Patients |
Discussion
Acne is a multifactorial skin condition affecting millions globally, particularly during adolescence and adulthood. This condition arises from factors, such as excess sebum production, clogged pores, bacterial overgrowth, and inflammation.27 Conventional treatments of acne, including antibiotics, retinoids, and benzoyl peroxide, are often effective but may lead to side effects, such as skin irritation and antibiotic resistance.28–30 In recent years, probiotics have become an alternative and complementary option in acne treatment, promising fewer side effects while promoting skin health.
Probiotics are live microorganisms that confer health benefits by balancing microbial populations when consumed or applied to skin.31,32 The mechanisms by which oral and topical probiotics address acne vulgaris differ but complement one another. Oral probiotics primarily function through the gut-skin axis and restore balance to the gut microbiome, reducing systemic inflammation that can increase the condition of acne33,34 By promoting the growth of beneficial bacteria, such as Lactobacillus and Bifidobacterium species, oral probiotics help decrease the levels of pro-inflammatory cytokines and regulate immune responses, indirectly benefiting skin health. This reduction in systemic inflammation often leads to less sebum production and fewer acne lesions.21 Meanwhile, topical probiotics function directly on skin by modulating the local microbiome. These probiotics compete with pathogenic bacteria, such as C. acne, reducing overgrowth and inflammation at the site of acne lesions. Topical probiotics enhance skin barrier function, increase hydration, and reduce irritation, creating a healthier environment for skin to heal.20,35
The most commonly used probiotics for acne vulgaris treatments are from the Lactobacillus strain, followed by Bacillus, Bifidobacterium, Enterococcus, and Escherichia coli. Lactobacillus strains were the most prevalent in the studies, showing substantial improvements in acne severity and skin condition. For instance, a study conducted in Korea showed that Lactobacillus plantarum CJLP55 significantly reduced acne lesions and improved skin hydration, enhancing skin lipid barrier.36 Lactobacillus rhamnosus SP1 decreased Insulin-like Growth Factor 1 (IGF-1) levels and enhanced the expression of Forkhead Box O1 (FOXO1),17 suggesting a modulation of insulin signaling pathways that may be relevant in acne pathogenesis.37 Elevated insulin levels, often due to resistance, can increase the production of androgens (male hormones), thereby stimulating sebaceous glands to produce more sebum. Excess sebum can clog hair follicles, producing a conducive environment for the growth of C. acne, a key contributor to inflammation.24 The study conducted in Spain showed that Lactobacillus rhamnosus and Arthrospira platensis caused significant reductions in inflammatory lesions.38 This result showed the role of Lactobacillus in improving acne symptoms through both immune modulation and skin health enhancement.34
In topical administration, a study from Taiwan showed that topical formulation containing a combination of Lactobacillus strains improved the moisture score of skin and reduced inflammation.25 This result supports the idea that topical probiotics may enhance skin barrier function and reduce acne-related inflammation directly at the site of application.15,20 Moreover, the study from China featuring topical lotion containing ferment lysate from Lactobacillus plantarum showed significant improvements in acne lesions and reduced sebum production.39 This result suggests that topical probiotics can exert direct effects on skin, improving local conditions and enhancing healing processes.
Previous studies using Bacillus strains showed positive effects on acne treatment. USA (United States of America) study found that oral supplementation with these probiotics decreased sebum excretion rates and also improved gut permeability markers, suggesting a systemic effect on skin health.40 This result shows the potential of Bacillus probiotics to influence both local and systemic factors contributing to acne. However, this Bacillus strain has not been tested for topical administration.
In the context of Bifidobacterium, the study from Italy showed the effectiveness of probiotic formulation containing Bifidobacterium breve. The results showed a significant reduction in inflammatory lesions compared to control groups.41 This suggests that Bifidobacterium strains may also play a crucial role in acne management, possibly through the modulation of the gut-skin axis. The strains help maintain a balanced gut microbiome, producing short-chain fatty acids (SCFAs) that possess anti-inflammatory properties, enhance intestinal barrier integrity, and reduce systemic inflammation connected to acne.42,43 Additionally, these strains modulate immune responses, influence hormonal regulation related to insulin and androgens, and produce metabolites that support skin barrier function and hydration.22,26 The gel preparation containing Bifidobacterium combined with Lactobacillus strains has been shown to improve the moisture score of skin in vivo, reduce the inflammation index, and accelerate the healing of acne-related wounds.25 It also diminished the appearance of brown patches and porphyrins on the face, which are connected to acne.25 The mechanism behind this effect includes the ability of probiotics to enhance skin barrier by promoting ceramide production, which improves hydration and reduces transepidermal water loss (TEWL).16,34 Additionally, probiotics modulate the immune response, reducing pro-inflammatory cytokines. In vitro, studies showed that this combination effectively suppressed the growth of C. acne, reduced pro-inflammatory cytokines, such as thymic stromal lymphopoietin (TSLP) and interleukin-33 (IL-33), and enhanced wound healing in human keratinocyte (HaCaT) cell cultures.25
Enterococcus faecalis was used in two studies, both showing the ability to improve acne lesions when applied topically. The first study showed significant improvement scores on the treated side compared to the control. However, the treatment success rate did not show a significant difference.14 The second study showed a marked reduction in inflammatory lesions with topical application of Enterococcus faecalis SL-5.18 The mechanism of action is believed to include the production of bacteriocins by Enterococcus faecalis, which target and reduce the population of C. acne, a key contributor to inflammation. This probiotic can modulate local immune responses by reducing the release of pro-inflammatory cytokines and promoting an anti-inflammatory environment, leading to reduced lesion formation and inflammation.14,18 Meanwhile, in a study conducted in Ukraine, Escherichia coli Nissle contributed to significant improvement in acne outcomes alongside dietary changes. This result shows the potential of Escherichia coli to modulate skin health through the gut microbiome.19
In general, these trials show the potential of probiotics, either topically or orally, to significantly reduce acne lesions and inflammation, improve skin health, and restore a healthy skin microbiome. However, some showed comparable efficacy to conventional treatments, such as benzoyl peroxide and antibiotics. These results suggest that probiotics could be a safe and effective alternative or adjunct to conventional acne treatments.
Despite the promising effects of probiotics on acne treatment, there are potential side effects and limitations that should be considered. Some individuals may experience mild gastrointestinal discomfort, such as bloating or diarrhea, especially with oral probiotics, though these effects are typically transient and resolve with continued use.11 Topically, while probiotics are generally well-tolerated, allergic reactions or skin irritation may occur in sensitive individuals.12 Additionally, the variability in individual responses to different probiotic strains poses a challenge in determining the most effective formulation for acne treatment.23 The need for further research to standardize dosages, strains, and administration methods is crucial to minimize these side effects and maximize the therapeutic benefits of probiotics in acne management. Furthermore, while probiotics may be beneficial for mild to moderate acne, their role in severe cases, where inflammation and bacterial resistance are more pronounced, remains uncertain and requires additional investigation.
Conclusion
In conclusion, the use of probiotics, both oral and topical, showed great promise as a treatment for acne. Oral probiotics modulated the gut microbiome and reduced systemic inflammation. Meanwhile, topical probiotics offered a direct, gentler method to balanced skin microbiome and reduced acne lesions. Advancements in studies showed that probiotics could become a mainstream treatment option for acne, offering a natural and effective alternative to conventional treatments. However, more standardized study was necessary to determine the most effective probiotic strains, combinations, and treatment regimens for different types of acne. While most studies highlighted the positive effects of probiotics, some limitations, such as strain-specific efficacy and variability in individual responses, must be addressed. Furthermore, the role of probiotics in managing severe acne requires additional investigation to assess their utility as an adjunctive therapy alongside conventional treatments.
Acknowledgments
The authors would like to thank the Rector of Universitas Padjadjaran for facilitating the APC via the Directorate of Research and Community Engagement.
Disclosure
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Gao R, Fu Q, Jiang HM, et al. Temporal metabolic and transcriptomic characteristics crossing islets and liver reveal dynamic pathophysiology in diet-induced diabetes. iScience. 2021;24(4):102265. doi:10.1016/j.isci.2021.102265
2. Karimkhani C. Global Skin Disease Morbidity and Mortality An Update From the Global Burden of Disease Study 2013. JAMA Dermathol. 2017;44113:1–7. doi:10.1001/jamadermatol.2016.5538
3. Dréno B, Dagnelie MA, Khammari A, Corvec S. The Skin Microbiome: a New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020;21(s1):18–24. doi:10.1007/s40257-020-00531-1
4. Szyguła R, Asanova B, Chilicka K, Dzie I. Microbiome and Probiotics in Acne Vulgaris — a Narrative Review. MDPI Life. 2022;12(422):1–11.
5. Carmona-cruz S, Orozco-covarrubias L, Sa M. The Human Skin Microbiome in Selected Cutaneous Diseases. Front Cell Infect Microbiol. 2022;12:1–9. doi:10.3389/fcimb.2022.834135
6. Article R, Pécastaings S, Corvec S, Veraldi S, Khammari A, Roques C. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. JEADV. 2018;32:5–14. doi:10.1111/jdv.15043
7. Huang C, Zhuo F, Han B, et al. The updates and implications of cutaneous microbiota in acne. Cell Biosci. 2023;13(113):1–18. doi:10.1186/s13578-023-01072-w
8. Legiawati L, Halim PA, Fitriani M, Hikmahrachim HG, Lim HW. Microbiomes in Acne Vulgaris and Their Susceptibility to Antibiotics in Indonesia: a Systematic Review and Meta-Analysis. MDPI Antibiotics. 2023;12(145):1–17.
9. Alkhawaja E, Alkhawaja B, Hammadi S, Abdelmalek M, Mahasneh N, Abdelmalek SM. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study. BMC Dermatol. 2020;20(17):1–9.
10. Probiotic J, Ls L, Deidda F, et al. New Approach in Acne Therapy A Specific Bacteriocin Activity and a Targeted Anti IL-8. J Clin Gastro. 2018;00(00):1–4. doi:10.1097/MCG.0000000000001053
11. Dore MP, Bibbò S, Fresi G, Bassotti G, Pes GM. Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2019;11(12):2913. doi:10.3390/NU11122913
12. Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019;25(5). doi:10.5070/D3255044062
13. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13(2):227–239. doi:10.1517/14740338.2014.872627
14. Han HS, Shin SH, Choi BY, et al. A split face study on the effect of an anti-acne product containing fermentation products of Enterococcus faecalis CBT SL-5 on skin microbiome modification and acne improvement. J Microbiol. 2022;60(5):488–495. doi:10.1007/S12275-022-1520-6
15. França K. Topical Probiotics in Dermatological Therapy and Skincare: a Concise Review. Dermatol Ther. 2021;11(1):71. doi:10.1007/S13555-020-00476-7
16. Camilion JV, Khanna S, Anasseri S, Laney C, Mayrovitz HN. Physiological, Pathological, and Circadian Factors Impacting Skin Hydration. Cureus. 2022;14(8). doi:10.7759/CUREUS.27666
17. Fabbrocini G, Bertona M, Picazo P-G, Monfrecola H, Emanuele E G, Emanuele E. Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne. Benef Microbes. 2016;7(5):625–630. doi:10.3920/BM2016.0089
18. Kang BS, Seo JG, Lee GS, et al. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol. 2009;47(1):101–109. doi:10.1007/S12275-008-0179-Y
19. Manzhalii E, Hornuss D, Stremmel W. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917. World J Gastroenterol. 2016;22(23):5415–5421. doi:10.3748/WJG.V22.I23.5415
20. Habeebuddin M, Karnati RK, Shiroorkar PN, et al. Topical Probiotics: more Than a Skin Deep. Pharmaceutics. 2022;14(3):557. doi:10.3390/PHARMACEUTICS14030557
21. Atabati H, Esmaeili SA, Saburi E, et al. Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: evidence from experimental and clinical studies. J Cell Physiol. 2020;235(12):8925–8937. doi:10.1002/JCP.29737
22. Varela-Trinidad GU, Domínguez-Díaz C, Solórzano-Castanedo K, Íñiguez-Gutiérrez L, de J H-FT, Fafutis-Morris M. Probiotics: protecting Our Health from the Gut. Microorganisms. 2022;10(7). doi:10.3390/MICROORGANISMS10071428
23. Forssten SD, Sindelar CW, Ouwehand AC. Probiotics from an industrial perspective. Anaerobe. 2011;17(6):410–413. doi:10.1016/J.ANAEROBE.2011.04.014
24. Nickles MA, Sharma D, Tsoukas MM, Ashack KA. Acne and insulin resistance: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;87(3):687–688. doi:10.1016/J.JAAD.2021.12.033
25. Ho HH, Chen CW, Yi TH, et al. Novel application of a Co-Fermented postbiotics of TYCA06/AP-32/CP-9/collagen in the improvement of acne vulgaris-A randomized clinical study of efficacy evaluation. J Cosmet Dermatol. 2022;21(11):6249–6260. doi:10.1111/JOCD.15228
26. Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF, Ma B, Bromberg JS. Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes. 2023;15(2). doi:10.1080/19490976.2023.2291164
27. Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023;36:101578. doi:10.1016/J.BBREP.2023.101578
28. Mohsin N, Hernandez LE, Martin MR, Does A, Nouri K. Acne treatment review and future perspectives. Dermatol Ther. 2022;35(9). doi:10.1111/DTH.15719
29. V. RR, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1–1006.e30. doi:10.1016/J.JAAD.2023.12.017
30. Calvisi L. Efficacy of a combined chemical peel and topical salicylic acid-based gel combination in the treatment of active acne. J Cosmet Dermatol. 2021;2(S2):2–6. doi:10.1111/JOCD.14281
31. Fijan S. Microorganisms with Claimed Probiotic Properties: an Overview of Recent Literature. Int J Environ Res Public Health. 2014;11(5):4745. doi:10.3390/IJERPH110504745
32. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of Action of Probiotics. Adv Nutr. 2019;10:S49–S66. doi:10.1093/ADVANCES/NMY063
33. D’Elios S, Trambusti I, Verduci E, et al. Probiotics in the prevention and treatment of atopic dermatitis. Pediatr Allergy Immunol. 2020;26(S26):43–45. doi:10.1111/PAI.13364
34. Gao T, Wang X, Li Y, Ren F. The Role of Probiotics in Skin Health and Related Gut–Skin Axis: a Review. Nutrients. 2023;15(14). doi:10.3390/NU15143123
35. Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020;182(1):39–46. doi:10.1111/bjd.18659
36. Kim MJ, Kim KP, Choi E, et al. Effects of Lactobacillus plantarum CJLP55 on Clinical Improvement, Skin Condition and Urine Bacterial Extracellular Vesicles in Patients with Acne Vulgaris: a Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2021;13(4). doi:10.3390/NU13041368
37. Napolitano M, Megna M, Monfrecola G, Wollina U. Insulin Resistance and Skin Diseases. Sci World J. 2015;2015(1):479354. doi:10.1155/2015/479354
38. Eguren C, Navarro-Blasco A, Corral-Forteza M, et al. A Randomized Clinical Trial to Evaluate the Efficacy of an Oral Probiotic in Acne Vulgaris. Acta Derm Venereol. 2024;104:adv33206. doi:10.2340/ACTADV.V104.33206
39. Cui H, Guo C, Wang Q, Feng C, Duan Z. A pilot study on the efficacy of topical lotion containing anti-acne postbiotic in subjects with mild -to -moderate acne. Front Med Lausanne. 2022;9:1064460. doi:10.3389/fmed.2022.1064460
40. Rybak I, Haas KN, Dhaliwal SK, et al. Prospective Placebo-Controlled Assessment of Spore-Based Probiotic Supplementation on Sebum Production, Skin Barrier Function, and Acne. J Clin Med. 2023;12(3):895. doi:10.1111/dth.15719
41. Rinaldi F, Marotta L, Mascolo A, et al. Facial Acne: a Randomized, Double-Blind, Placebo-Controlled Study on the Clinical Efficacy of a Symbiotic Dietary Supplement. Dermatol Ther. 2022;12(2):577–589. doi:10.1007/S13555-021-00664-Z
42. Chandrasekaran P, Weiskirchen S, Weiskirchen R. Effects of Probiotics on Gut Microbiota: an Overview. Int J Mol Sci. 2024;25(11):6022. doi:10.3390/IJMS25116022
43. Fusco W, Lorenzo MB, Cintoni M, et al. Short-Chain Fatty-Acid-Producing Bacteria: key Components of the Human Gut Microbiota. Nutrients. 2023;15(9):2211. doi:10.3390/NU15092211
44. Lebeer S, Oerlemans EFM, Claes I, et al. Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli. Cell Reports Med. 2022;3(2):100521. doi:10.1016/J.XCRM.2022.100521
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.